Loading company…
PanGenetics developed biological therapeutics, including an antibody targeting nerve growth factor.
Founded in 1995 and based in Utrecht, Netherlands, PanGenetics developed biological therapeutics. In November 2009, Abbott Laboratories acquired global rights to an antibody to nerve growth factor for USD 170 mn plus earn-out payments. The company later appeared in a Trade Sale valued at USD 190 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in